IL17A and COVID-19: Results from the hamster challenge study demonstrated a strong anti-inflammatory potential of A64, as the mRNA expression of inflammatory cytokines such as IL-6, IL-17A, and TNF-α (all of which have been strongly correlated with COVID-19 severity) was significantly reduced.